| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 349.894 | 468.677 | 515.414 | 575.091 | 539.617 | 476.300 |
| Total Income - EUR | 31 | 22 | 10 | 0 | 359.572 | 498.835 | 515.414 | 575.094 | 539.618 | 537.118 |
| Total Expenses - EUR | 73 | 70 | 44 | 3 | 364.205 | 492.954 | 526.852 | 565.033 | 679.149 | 554.040 |
| Gross Profit/Loss - EUR | -42 | -48 | -34 | -3 | -4.633 | 5.881 | -11.437 | 10.061 | -139.532 | -16.922 |
| Net Profit/Loss - EUR | -42 | -48 | -34 | -3 | -8.126 | 2.167 | -16.276 | 4.296 | -143.576 | -16.922 |
| Employees | 0 | 0 | 0 | 0 | 9 | 16 | 15 | 15 | 13 | 10 |
Check the financial reports for the company - Probioplast Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 12.111 | 43.866 | 35.435 | 24.026 | 41.012 | 30.508 |
| Current Assets | 998 | 939 | 290 | 282 | 118.343 | 55.290 | 138.922 | 177.441 | 65.069 | 76.058 |
| Inventories | 0 | 0 | 0 | 0 | 11.838 | 19.030 | 75.469 | 147.625 | 56.950 | 52.323 |
| Receivables | 162 | 161 | 158 | 155 | 13.839 | 1.233 | 4.373 | 9.119 | 3.791 | 9.688 |
| Cash | 835 | 779 | 132 | 127 | 92.666 | 35.026 | 59.080 | 20.697 | 4.328 | 14.048 |
| Shareholders Funds | -206 | -252 | -281 | -279 | -8.399 | -6.073 | -22.215 | -17.988 | -247.302 | -262.843 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.204 | 1.191 | 572 | 561 | 138.917 | 105.230 | 196.572 | 219.455 | 353.384 | 369.409 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4332
|
|||||||||
Comments - Probioplast Grup Srl